Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wataru Obara

Showing results (131-140 of 170) with videos related to

Pageof 17
Sort By:
Neurourology and Urodynamics|July 25, 2019
Usefulness of a novel classification based on perioperative changes of membranous urethral length using hierarchical cluster analysis of urinary incontinence and overactive bladder symptoms after robot-assisted radical prostatectomy: A prospective observational studyMitsutaka Onoda, Nobuhiro Haga, Yoshimasa Kurimura, et al.
The Journal of Molecular Diagnostics : JMD|February 1, 2024
The Clinical Validity of Urinary Pellet DNA Monitoring for the Diagnosis of Recurrent Bladder CancerMasakazu Abe, Hayato Hiraki, Takashi Tsuyukubo, et al.
Human Molecular Genetics|August 18, 2022
Genomic features of renal cell carcinoma developed during end-stage renal disease and dialysisTodd A Johnson, Shigekatsu Maekawa, Masashi Fujita, et al.
Clinical and Experimental Nephrology|October 25, 2024
Efficacy of valganciclovir prophylaxis in kidney transplant recipients following low-dose rituximab induction therapy: a multicenter retrospective studyTomohiro Takehara, Hayato Nishida, Kazunobu Ichikawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 14, 2020
Impact of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma receiving systemic tyrosine kinase inhibitor therapy: A multicenter retrospective studyShingo Hatakeyama, Sei Naito, Kazuyuki Numakura, et al.
International Journal of Clinical Oncology|September 22, 2023
Preoperative prognostic model for localized and locally advanced renal cell carcinoma: Michinoku Japan Urological Cancer Study GroupShigemitsu Horie, Sei Naito, Shingo Hatakeyama, et al.
International Journal of Clinical Oncology|January 1, 2022
Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective studyRenpei Kato, Sei Naito, Kazuyuki Numakura, et al.
Urologic Oncology|September 21, 2021
External validation of the REMARCC model for the selection of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma: A multicenter retrospective studyKazutaka Okita, Shingo Hatakeyama, Sei Naito, et al.
Cancer Medicine|October 31, 2023
The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non-clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group databaseTomoyuki Koguchi, Sei Naito, Shingo Hatakeyama, et al.
Cancer Medicine|July 27, 2021
Outcomes of axitinib versus sunitinib as first-line therapy to patients with metastatic renal cell carcinoma in the immune-oncology eraKazuyuki Numakura, Yumin Muto, Sei Naito, et al.
Pageof 17

Showing results (131-140 of 170) with videos related to

Sort By:
Pageof 17
Neurourology and Urodynamics|July 25, 2019
Usefulness of a novel classification based on perioperative changes of membranous urethral length using hierarchical cluster analysis of urinary incontinence and overactive bladder symptoms after robot-assisted radical prostatectomy: A prospective observational studyMitsutaka Onoda, Nobuhiro Haga, Yoshimasa Kurimura, et al.
The Journal of Molecular Diagnostics : JMD|February 1, 2024
The Clinical Validity of Urinary Pellet DNA Monitoring for the Diagnosis of Recurrent Bladder CancerMasakazu Abe, Hayato Hiraki, Takashi Tsuyukubo, et al.
Human Molecular Genetics|August 18, 2022
Genomic features of renal cell carcinoma developed during end-stage renal disease and dialysisTodd A Johnson, Shigekatsu Maekawa, Masashi Fujita, et al.
Clinical and Experimental Nephrology|October 25, 2024
Efficacy of valganciclovir prophylaxis in kidney transplant recipients following low-dose rituximab induction therapy: a multicenter retrospective studyTomohiro Takehara, Hayato Nishida, Kazunobu Ichikawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 14, 2020
Impact of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma receiving systemic tyrosine kinase inhibitor therapy: A multicenter retrospective studyShingo Hatakeyama, Sei Naito, Kazuyuki Numakura, et al.
International Journal of Clinical Oncology|September 22, 2023
Preoperative prognostic model for localized and locally advanced renal cell carcinoma: Michinoku Japan Urological Cancer Study GroupShigemitsu Horie, Sei Naito, Shingo Hatakeyama, et al.
International Journal of Clinical Oncology|January 1, 2022
Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective studyRenpei Kato, Sei Naito, Kazuyuki Numakura, et al.
Urologic Oncology|September 21, 2021
External validation of the REMARCC model for the selection of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma: A multicenter retrospective studyKazutaka Okita, Shingo Hatakeyama, Sei Naito, et al.
Cancer Medicine|October 31, 2023
The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non-clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group databaseTomoyuki Koguchi, Sei Naito, Shingo Hatakeyama, et al.
Cancer Medicine|July 27, 2021
Outcomes of axitinib versus sunitinib as first-line therapy to patients with metastatic renal cell carcinoma in the immune-oncology eraKazuyuki Numakura, Yumin Muto, Sei Naito, et al.
Pageof 17